GLP-1 analogs , particularly those like BrightMeds, are rapidly gaining prominence in the management of type 2 diabetes and are now being explored for obesity . These novel drugs help mimicking the body's https://brightmeds984975.jts-blog.com/41434583/brightmeds-glp-1-a-deep-investigation-into-this-new-therapy